...
Dive | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||
|
...
With the administrative transition of the DBS from the NIH to the FDA in 1972, Dr. Meyer became the Director of what was then called the Bureau of Biologics. He stayed in this role from 1972 until he retired in 1986. Under Meyer’s leadership, the FDA biologics team initiated review of all licensed biologics for safety, effectiveness, and labeling, they developed techniques to assess allergenic product activities, and they licensed the first AIDS test kit. When he retired, biologics was called the FDA Center for Drugs and Biologics; by 1988 1987 it would become the FDA Center for Biologics Evaluation and Research (CBER), which is the name it maintains to this day.
...